ACTIVE_NOT_RECRUITING

Technology-assisted Language Intervention (TALI)

Conditions

Hearing Loss, Bilateral Language Development hearing loss randomized clinical trial intervention

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is testing the effectiveness of augmentative and alternative communication technology among deaf or hard of hearing children for improving language development. Children will be randomized to receive either the technology intervention or treatment as usual

Official Title

Technology-assisted Language Intervention for Children Who Are Deaf/Hard-of-hearing (TALI)

Quick Facts

Study Start:2020-10-15

Study Completion:2026-03-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:ACTIVE_NOT_RECRUITING

Study ID

NCT04857255

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:3 Years to 10 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:Yes

Standard Ages:CHILD

Inclusion Criteria	Exclusion Criteria
* Age 3-10 years * Documented permanent bilateral hearing loss with severity levels clinically defined moderate to profound). * Identified with a language deficit, defined by either the ratio of language standard scores to nonverbal intelligence quotient \<.85 or a differences in nonverbal IQ and language standard scores of 10 points. Language scores may either be receptive or expressive. * Currently receiving speech-language therapy.	* primary language other than English * significant motor impairments * nonverbal IQ \<80 * children with severe communication disorders (i.e. autism spectrum disorders).

Inclusion Criteria

Exclusion Criteria

* Age 3-10 years
* Documented permanent bilateral hearing loss with severity levels clinically defined moderate to profound).
* Identified with a language deficit, defined by either the ratio of language standard scores to nonverbal intelligence quotient \<.85 or a differences in nonverbal IQ and language standard scores of 10 points. Language scores may either be receptive or expressive.
* Currently receiving speech-language therapy.

* primary language other than English
* significant motor impairments
* nonverbal IQ \<80
* children with severe communication disorders (i.e. autism spectrum disorders).

Contacts and Locations

Principal Investigator

Jareen Meinzen-Derr

PRINCIPAL_INVESTIGATOR

Children's Hospital Medical Center, Cincinnati

Study Locations (Sites)

Children's Hospital of Colorado

Aurora, Colorado, 80045

United States

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229

United States

Collaborators and Investigators

Sponsor: Children's Hospital Medical Center, Cincinnati

Jareen Meinzen-Derr, PRINCIPAL_INVESTIGATOR, Children's Hospital Medical Center, Cincinnati

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2020-10-15

Study Completion Date2026-03-31

Study Record Updates

Study Start Date2020-10-15

Study Completion Date2026-03-31

Terms related to this study

Keywords Provided by Researchers

hearing loss
randomized clinical trial
intervention
language development

Additional Relevant MeSH Terms

Hearing Loss, Bilateral
Language Development